Public Meeting Agenda

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C; Brian L. Strom; Gillian J. Buckley

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C; Strom BL, Buckley GJ, editors. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington (DC): National Academies Press (US); 2017 Mar 28.

Cover of A National Strategy for the Elimination of Hepatitis B and C

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report.

Show details

< Prev Next >

Appendix CPublic Meeting Agenda

COMMITTEE ON A NATIONAL STRATEGY FOR THE ELIMINATION OF HEPATITIS B AND C

National Academy of Sciences Building, 2100 Constitution Avenue NW
Washington, DC 20001

June 8, 2016

Room 120

PHASE TWO ORIENTATION

9:00-9:15	Welcome and Introductions Brian Strom, Committee Chair
9:15-10:15	Sponsor Orientation to Phase Two John Ward, Director, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC) Nadine Gracia, Deputy Assistant Secretary for Minority Health, Office of Minority Health, Department of Health and Human Services (HHS) Michael Fried, Board Member, American Association for the Study of Liver Diseases Ryan Clary, Executive Director, National Viral Hepatitis Roundtable
10:15-10:30	Break

SCREENING AND REFERRALS TO CARE

10:30-12:00

Panel Discussion on Novel Strategies for Testing and Follow-Up

Kathleen Maurer, Moderator
- Sabrina Assoumou, Assistant Professor of Medicine, Boston University
- Alicia Ifkovic-Mau, Correctional Counselor Supervisor, Department of Corrections, State of Connecticut
- William Stauffer, Professor of Medicine and Pediatrics, Division of Infectious Diseases and International Medicine, University of Minnesota
- David Thomas, Director, Division of Infectious Diseases, Johns Hopkins School of Medicine

12:00-1:00

Lunch

INNOVATIVE FINANCING FOR HEPATITIS C TREATMENTS

1:00-2:30	Panel Discussion on Paying for Cures Neeraj Sood, Moderator Tim Gronniger, Deputy Chief of Staff, Centers for Medicare & Medicaid Services Steve Miller, Chief Medical Officer, Express Scripts Coy Stout, Vice President, Managed Markets, Gilead
2:30-2:45	Break
2:45-4:15	Panel Discussion on Hepatitis C Treatment in Government Programs Brian Strom, Moderator John Coster, Director, Division of Pharmacy, Center for Medicaid and Children's Health Insurance Program (CHIP) Services, Centers for Medicare & Medicaid Services Kimberley Lenz, Clinical Pharmacy Manager, MassHealth Robert Zavoski, Medical Director, Connecticut Department of Social Services
4:15-4:45	Public Health and Drug Pricing: Policy Solutions for Population Coverage Joshua Sharfstein, Professor of the Practice, Johns Hopkins Bloomberg School of Public Health
5:00	Adjourn
6:30	Working dinner for committee and staff at Circle Bistro

June 9, 2016

Members' Room

INTERNATIONAL PROGRAMS ON VIRAL HEPATITIS

9:00-9:05	Welcome Brian Strom, Committee Chair
9:05-9:35	Global Momentum for Viral Hepatitis Elimination Stefan Wiktor, Team Lead, Global Hepatitis Program, World Health Organization (WHO)
9:40-10:10	An Australian Perspective on Hepatitis Elimination Ben Cowie, Director, WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, University of Melbourne
10:10-10:30	Break

HARM REDUCTION AND NEEDLE EXCHANGE

10:30-12:00	Panel Discussion on Harm Reduction in Rural Areas and Small Towns Shruti Mehta, Moderator Jerome Adams, Health Commissioner, Indiana State Department of Health Jennifer Havens, Associate Professor, Center for Drug and Alcohol Research, University of Kentucky College of Medicine Robin Pollini, Senior Research Scientist, Pacific Institute for Research and Evaluation
12:00-1:00	Lunch

INTEGRATING CLINICAL AND PUBLIC HEALTH DATA

1:00-2:30

Panel Discussion on Using Electronic Records for Clinical Medicine and Public Health

Grace Wang, Moderator
- Jeff Duchin, Professor in Medicine, Division of Allergy and Infectious Diseases, University of Washington
- Michael Klompas, Associate Professor and Infectious Diseases Specialist, Harvard Medical School and Harvard Pilgrim Health Care Institute
- Chia Wang, Infectious Diseases Specialist and Clinical Associate Professor of Medicine, Virginia Mason Medical Center, International Community Health Services and University of Washington

Bookshelf ID: NBK442224

Contents

< Prev Next >

PubReader
Print View
Cite this Page
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C; Strom BL, Buckley GJ, editors. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Washington (DC): National Academies Press (US); 2017 Mar 28. Appendix C, Public Meeting Agenda.
PDF version of this title (11M)

Recent Activity

Clear Turn Off Turn On

Public Meeting Agenda - A National Strategy for the Elimination of Hepatitis B a...
Public Meeting Agenda - A National Strategy for the Elimination of Hepatitis B and C

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf